Repros (RPRX) Submits Request to Withdrawal S-1 Filing, Cites Market Conditions
Repros Therapeutics Inc. (Nasdaq: RPRX) hereby respectfully requests, pursuant to Rule 477 under the Securities Act of 1933, as amended, the withdrawal, effective as of the date hereof, of the Company’s Registration Statement on Form S-1 (File No. 333-178613) filed with the United States Securities and Exchange Commission on December 19, 2011, together with all exhibits thereto.
The Company submits this request for withdrawal as the Company believes that current market conditions make proceeding with this offering unattractive at this time. There has been no circulation of preliminary prospectuses in connection with this offering, the Registration Statement has not been declared effective by the Commission and none of the Company’s securities have been sold in connection with this offering. The Company also acknowledges that no refund will be made for fees paid to the Commission in connection with filing of the Registration Statement. However, the Company requests, in accordance with Rule 457(p) under the Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Company’s account, to be offset against the filing fee for any future registration statement(s).
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
The Company submits this request for withdrawal as the Company believes that current market conditions make proceeding with this offering unattractive at this time. There has been no circulation of preliminary prospectuses in connection with this offering, the Registration Statement has not been declared effective by the Commission and none of the Company’s securities have been sold in connection with this offering. The Company also acknowledges that no refund will be made for fees paid to the Commission in connection with filing of the Registration Statement. However, the Company requests, in accordance with Rule 457(p) under the Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Company’s account, to be offset against the filing fee for any future registration statement(s).
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Euroseas (ESEA) commences 13.9M rights offering
- General Electric (GE) Makes $300M Investment in Large Brazilian Conglomerate
- Dow Chemical (DOW) Wins $2.16B in K-Dow Arbitration
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
